14 hours ago
Novo Nordisk cuts 2025 guidance as drug copycats hit Wegovy sales, posts first-quarter profit beat
Cnbc.com and 3 more

Vote 4
References
Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow
Wegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off

Ozempic maker cuts forecasts after copycat versions hit sales

0 Comments
Be the first to comment
Add your thoughts and get the conversation going.
Related Articles
Explore Your Interests
Create an account and enjoy content that interests you with your personalized feed
Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.